CoChat

Antidepressant Pharmacotherapy: Economic Evaluation of Fluoxetine, Paroxetine and Sertraline in a Health Maintenance Organization

Sclar, D A, Robison, L M, Skaer, T L, Galin, R S, Legg, R F, Nemec, N L, Hughes, T E, Buesching, D P, Morgan, M · 1995 · Journal of International Medical Research
Cited by 82

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

The present study was designed to compare direct health service expenditures, for the treatment of depression, among patients enrolled in a health maintenance organization, and prescribed one of three selective serotonin reuptake inhibitors, fluoxetine, paroxetine or sertraline. Information regarding depression-related health service use was derived from the computer archive of a network-model health maintenance organization system serving 700 000 beneficiaries. A total of 744 health maintenance organization beneficiaries were found to satisfy the study selection criteria. Multivariate regression analysis was used to determine the incremental influence of selected demographic, clinical, financial and provider characteristics on health service expenditures related to the treatment of depression (ICD-9-CM, or DSM-IV code 296.2) 1 year after the start of antidepressant pharmacotherapy. Multivariate findings indicate that treatment with paroxetine increases average expenditures for physician visits ($31.93; P ≤ 0.05), psychiatric visits ($19.33; NS), laboratory tests ($2.35; P ≤ 0.05), hospitalizations ($85.33; P ≤ 0.05), psychiatric hospitalizations ($82.01; P ≤ 0.05), and antidepressant pharmacotherapy ($63.72; P ≤ 0.05), for a total per capita increase in health service use of $284.68 ( P ≤ 0.05), compared with treatment with fluoxetine. Sertraline treatment increases average expenditures for physician visits ($21.74; P ≤ 0.05), psychiatric visits ($56.79; P ≤ 0.05), laboratory tests ($1.21; P ≤ 0.05), hospitalizations ($70.59; P ≤ 0.05), psychiatric hospitalizations ($95.75; P ≤ 0.05), and antidepressant pharmacotherapy ($69.85; P ≤ 0.05), for a total per capita increase in health service use of $315.96 ( P ≤ 0.05), compared with treatment with fluoxetine. Economic comparisons between paroxetine and sertraline did not demonstrate any significant differences in expenditures for the health services examined.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/030006059502300601

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 82

Metadata

Authors
Sclar, D. A., Robison, L. M., Skaer, T. L., Galin, R. S., Legg, R. F., Nemec, N. L., Hughes, T. E., Buesching, D. P., & Morgan, M.
Venue
Journal of International Medical Research
Published
1995-11
Volume
23
Issue
6
Pages
395-412
ISSN
  • 0300-0605 (ISSN-L)
  • 1473-2300
OpenAlex
W2095901534
Cited by
82
References
3
FWCI
30.34
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Antidepressant Pharmacotherapy: Economic Evaluation of Fluoxetine, Paroxetine and Sertraline in a Health Maintenance Organization. https://app.cochat.ai/papers/10.1177/030006059502300601
The paper
Sclar, D. A., Robison, L. M., Skaer, T. L., Galin, R. S., Legg, R. F., Nemec, N. L., Hughes, T. E., Buesching, D. P., & Morgan, M. (1995). Antidepressant Pharmacotherapy: Economic Evaluation of Fluoxetine, Paroxetine and Sertraline in a Health Maintenance Organization. Journal of International Medical Research. https://doi.org/10.1177/030006059502300601

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.